{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T17:55:27Z","timestamp":1765216527506,"version":"3.46.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.compbiomed.2025.111250","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:39:43Z","timestamp":1761323983000},"page":"111250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Computational investigation of hepatocyte growth factor receptor-ligand interactions for the identification of novel therapeutic inhibitors"],"prefix":"10.1016","volume":"198","author":[{"given":"Mahir","family":"Azmal","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7258-9113","authenticated-orcid":false,"given":"Jibon Kumar","family":"Paul","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5065-604X","authenticated-orcid":false,"given":"Fatema Sultana","family":"Prima","sequence":"additional","affiliation":[]},{"given":"Md Naimul","family":"Haque Shohan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2137-9621","authenticated-orcid":false,"given":"Raisa","family":"Alam","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-3916","authenticated-orcid":false,"given":"Ajit","family":"Ghosh","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.111250_bib1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib2","first-page":"3","article-title":"The met oncogene: from detection by transfection to transmembrane receptor for hepatocyte growth factor","volume":"7","author":"Cooper","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.compbiomed.2025.111250_bib3","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/sj.emboj.7600243","article-title":"Crystal structure of the HGF \u03b2\u2010chain in complex with the Sema domain of the Met receptor","volume":"23","author":"Jennifer","year":"2004","journal-title":"The EMBO J."},{"key":"10.1016\/j.compbiomed.2025.111250_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/34657","article-title":"Induction of epithelial tubules by growth factor HGF depends on the STAT pathway","volume":"391","author":"Boccaccio","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2025.111250_bib5","first-page":"969","article-title":"The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment","volume":"7","author":"Parikh","year":"2014","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.compbiomed.2025.111250_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3835(95)03915-J","article-title":"Selective tumorigenesis in non-parenchymal liver epithelial cell lines by hepatocyte growth factor transfection","volume":"96","author":"Johnson","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.compbiomed.2025.111250_bib7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2025.111250_bib8","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1158\/0008-5472.CAN-08-1643","article-title":"Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations","volume":"68","author":"Yano","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.111250_bib9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","article-title":"Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion","volume":"487","author":"Straussman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2025.111250_bib10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1158\/1535-7163.MCT-11-0754","article-title":"MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells","volume":"11","author":"Chen","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.compbiomed.2025.111250_bib11","doi-asserted-by":"crossref","first-page":"11026","DOI":"10.1073\/pnas.0914295107","article-title":"Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion","volume":"107","author":"Grugan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.compbiomed.2025.111250_bib12","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1200\/JCO.2011.35.4928","article-title":"MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib","volume":"29","author":"Lennerz","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib13","doi-asserted-by":"crossref","first-page":"14240","DOI":"10.1073\/pnas.1017536108","article-title":"Wild-type p53 controls cell motility and invasion by dual regulation of MET expression","volume":"108","author":"Hwang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.compbiomed.2025.111250_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12010-021-03791-7","article-title":"Molecular docking of phytochemicals targeting GFRs as therapeutic sites for cancer: an in silico study","volume":"194","author":"Mendie","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.compbiomed.2025.111250_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.compbiomed.2025.111250_bib17","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.biopha.2018.07.055","article-title":"Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors","volume":"106","author":"Aliebrahimi","year":"2018","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.compbiomed.2025.111250_bib18","article-title":"Targeted inhibition of c-MET by podophyllotoxin promotes caspase-dependent apoptosis and suppresses cell growth in gefitinib-resistant non-small cell lung cancer cells","volume":"80","author":"Oh","year":"2021","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.compbiomed.2025.111250_bib19","article-title":"Identification of phytochemicals targeting c-Met kinase domain using consensus docking and molecular dynamics simulation studies","volume":"76","author":"S","year":"2018","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.compbiomed.2025.111250_bib20","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/sj.emboj.7600243","article-title":"Crystal structure of the HGF \u03b2\u2010chain in complex with the sema domain of the met receptor","volume":"23","author":"Stamos","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.compbiomed.2025.111250_bib21","doi-asserted-by":"crossref","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinforma."},{"key":"10.1016\/j.compbiomed.2025.111250_bib22","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1110\/ps.9.9.1753","article-title":"Modeling of loops in protein structures","volume":"9","author":"Fiser","year":"2000","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"10.1016\/j.compbiomed.2025.111250_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.compbiomed.2025.111250_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304490","article-title":"A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: molecular docking, ADME profiling and molecular dynamics simulations","volume":"19","author":"Azmal","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.111250_bib25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/molecules28020776","article-title":"Evaluation of free online ADMET tools for academic or small biotech environments","volume":"28","author":"Dulsat","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2025.111250_bib26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/ph17060725","article-title":"Study of the lipophilicity and ADMET parameters of new anticancer diquinothiazines with pharmacophore substituents","volume":"17","author":"Klimoszek","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiomed.2025.111250_bib27","first-page":"106","article-title":"Phytochemistry of plants in the genus Vepris: a review and in silico analysis of their ADMET properties, South Afr","volume":"157","author":"Ojuka","year":"2023","journal-title":"J. Bot., Le"},{"key":"10.1016\/j.compbiomed.2025.111250_bib28","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1038\/s41598-025-86809-y","article-title":"Prediction of ADMET profile and anti-inflammatory potential of chamuangone","volume":"15","author":"Jantarawong","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.111250_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"key":"10.1016\/j.compbiomed.2025.111250_bib30","series-title":"Mol. Docking Comput.-Aided Drug Des.","first-page":"463","article-title":"Chapter 22 - docking-based virtual screening using PyRx tool: autophagy target Vps34 as a case study","author":"Kondapuram","year":"2021"},{"key":"10.1016\/j.compbiomed.2025.111250_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2025.111250_bib32","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.111250_bib33","doi-asserted-by":"crossref","DOI":"10.1063\/1.4872239","article-title":"Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity","volume":"140","author":"Harrach","year":"2014","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2025.111250_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1758834011408636","article-title":"The role of the c-Met pathway in lung cancer and the potential for targeted therapy","volume":"3","author":"Sattler","year":"2011","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fcell.2020.00152","article-title":"Targeting the HGF\/MET axis in cancer therapy: challenges in resistance and opportunities for improvement","volume":"8","author":"Huang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1586\/era.09.43","article-title":"Targeting the met signaling pathway in renal cancer, expert rev","volume":"9","author":"Giubellino","year":"2009","journal-title":"Anticancer Ther"},{"key":"10.1016\/j.compbiomed.2025.111250_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/JTO.0b013e3182417e44","article-title":"MET signaling: novel targeted inhibition and its clinical development in lung cancer","volume":"7","author":"Feng","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413692","article-title":"The MET oncogene network of interacting cell surface proteins","volume":"25","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2025.111250_bib39","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3390\/ph17111473","article-title":"The MET oncogene: an update on targeting strategies","volume":"17","author":"Gallo","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiomed.2025.111250_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1383456","article-title":"Targeting PD-1\/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges","volume":"15","author":"Javed","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1296341","article-title":"PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment","volume":"14","author":"Parvez","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118014","article-title":"Combination therapy with immune checkpoint inhibitors in colorectal cancer: challenges, resistance mechanisms, and the role of microbiota","volume":"186","author":"Rahimi","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiomed.2025.111250_bib43","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/BST20200394","article-title":"State of the structure address on MET receptor activation by HGF","volume":"49","author":"Linossi","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.compbiomed.2025.111250_bib44","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.24796","article-title":"Hepatocyte growth factor (HGF)\/c-Met signaling is required for stem cell mediated liver regeneration","volume":"55","author":"Ishikawa","year":"2012","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.compbiomed.2025.111250_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.994528","article-title":"c-Met-integrin cooperation: mechanisms, tumorigenic effects, and therapeutic relevance","volume":"10","author":"Stanislovas","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.compbiomed.2025.111250_bib46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10555-022-10048-0","article-title":"Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance","volume":"41","author":"Islam","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.compbiomed.2025.111250_bib47","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1158\/1078-0432.CCR-12-2832","article-title":"Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.111250_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-024-01899-w","article-title":"Therapeutic advances of targeting receptor tyrosine kinases in cancer","volume":"9","author":"Tomuleasa","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.compbiomed.2025.111250_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-018-0796-y","article-title":"Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.compbiomed.2025.111250_bib50","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/1535-7163.MCT-16-0771","article-title":"MET tyrosine kinase inhibition enhances the Antitumor efficacy of an HGF antibody","volume":"16","author":"Farrell","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.compbiomed.2025.111250_bib51","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fchem.2020.00726","article-title":"Computational approaches in preclinical studies on drug discovery and development","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiomed.2025.111250_bib52","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3390\/biom14101330","article-title":"A survey on computational methods in drug discovery for neurodegenerative diseases","volume":"14","author":"Vicidomini","year":"2024","journal-title":"Biomolecules"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525016038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525016038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T17:52:54Z","timestamp":1765216374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525016038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"alternative-id":["S0010482525016038"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111250","relation":{},"ISSN":["0010-4825"],"issn-type":[{"type":"print","value":"0010-4825"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational investigation of hepatocyte growth factor receptor-ligand interactions for the identification of novel therapeutic inhibitors","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111250"}}